Navigation Links
Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Date:9/17/2013

, September 24, 1:45–2:45 CET, General Poster Session

  • Empagliflozin Improves Blood Pressure in Patients with Type 2 Diabetes (T2DM) and Hypertension (Presenting Author: I. Tikkanen) [Poster No. 942]
  • Empagliflozin Improved Glycemic Parameters and Cardiovascular Risk Factors in Patients with Type 2 Diabetes (T2DM): Pooled Data from Four Pivotal Phase III Trials (Presenting Author: T. Hach) [Poster No. 943]
  • Design of the Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus (Presenting Author: S. E. Inzucchi) [Poster No. 944]

Wednesday, September 25, 12:30–1:30 CET, General Poster Session

  • Empagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) and Stage 3A, 3B and 4 Chronic Kidney Disease (CKD) (Presenting Author: A. Mithal) [Poster No. 952]

Thursday, September 26, 3:00 – 4:30 CET, Oral Presentation

  • The Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitor Empagliflozin Improves Glycemic Control in Patients with Type 1 Diabetes: A Single-Arm Clinical Trial (Presenting Author: B. A. Perkins) [Oral Presentation No. 31]

Linagliptin Data
A total of nine clinical and pre-clinical abstracts for linagliptin will also be presented. Linagliptin is an inhibitor of the enzyme, dipeptidyl peptidase-4 (DPP-4), which breaks down the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) that are involved with regulating blood sugar.2

Details of all presentations for linagliptin are as follows:1

Wednesday, September 25, 10:45 – 12:15 CET, Oral Presentation

  • Baseline Characteristics of Participants Enrolled in the
    '/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
(Date:8/28/2015)... 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... the acquisition of leading OTC brands from GSK in ... transaction is a clear demonstration of Perrigo,s unique ability ... distribution network spanning 36 countries.  Perrigo ... commented, "We are excited to complete this transaction, which ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... 27 Puroast(R) Low Acid Coffee,has conducted both ... its great tasting, gourmet coffee provides symptom relief ... brew. Puroast(R) achieves,this without extractions, substitutes or additives; ... full-bodied taste., Prior chemistry research at University ...
... Emerging Data Shows Encouraging Response in CF Patients ... BETHESDA, Md., March 27 The Cystic Fibrosis ... that targets a,basic defect in CF, showed promising results ... carry the G551D mutation of CF. The drug is,being ...
Cached Medicine Technology:Low Acid Coffee Backed By Scientific Research 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 3
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made possible ... lives of patients, according to a newly published report. Surviving Mesothelioma has more ... article. , The authors of the new paper focus on several types ...
(Date:8/29/2015)... ... 2015 , ... Brands like Toppik , Eau Thermale Avene and Bliss ... a threshold of $49.00 was required to qualify for free standard shipping,” said Jennifer ... shipping for customers regardless of the item’s selling price.” , With competitive pricing in ...
(Date:8/29/2015)... ... ... ProDrop Particles includes over 40 particle backdrops designed for use in ... users can shrink and stretch in the Final Cut Pro X timeline. Choose from ... scale, speed, range, and flare attributes with intuitive controls found in the top-right inspector ...
(Date:8/29/2015)... New York, NY (PRWEB) , ... August 29, ... ... consistently successful results and include treating the localized area with stretching, soft tissue ... and a neutral pelvic position have shown through research to improve treatment ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... freely market and sell Arterosil and Arterosil HP, and that all claims and ... sued Vascular Health Sciences, LLC (VHS) in the United States District Court for ...
Breaking Medicine News(10 mins):Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... this New Digest: , , Summary of ... the Journal of Clinical Oncology ,showing no ... cancer whose ovaries were left intact during cancer ... removed., Quote for attribution from Beth Karlan, MD, ...
... and Spanish . , A research work carried ... University of Granada has carried out an analysis of the ... most of them belong to the group of lactic bacteria, which ... for health. The doctoral thesis by Antonio M. Martn Platero ...
... High-Quality Care to Homeless Animals and the Public, Regardless ... Spay/Neuter 12,000 Cats and Dogs in 2009 -- Double ... The San Francisco SPCA today announced the opening of ... home of its nonprofit Veterinary Hospital, Spay/Neuter Clinic and ...
... Collaborate and Achieve ComplianceHOPKINTON, Mass., Jan. 28 ... world leader in information infrastructure solutions, today announced ... (DCM) to centrally store, review, approve and manage ... procedures (SOPs). As a result, RadPharm has ...
... Sunday throughout February, Sharing Miracles , a 30-minute ... inspirational stories of real patients, will feature television actress ... the hit sitcom Family Ties . Sharing ... across the United States. Though perhaps best known for ...
... Swiss Re,s Employer Stop Loss insurance coverage is ... in self-funding their employee health plans in the United ... liability and benefit from self-funding their employee health plans. ... in all 50 states and the District of Columbia ...
Cached Medicine News:Health News:Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause 2Health News:Most bacteria from craft goat's cheese come from lactic acid and could be beneficial for health 2Health News:San Francisco SPCA Dramatically Expands Charitable Veterinary Care With Opening of Leanne B. Roberts Animal Care Center 2Health News:San Francisco SPCA Dramatically Expands Charitable Veterinary Care With Opening of Leanne B. Roberts Animal Care Center 3Health News:San Francisco SPCA Dramatically Expands Charitable Veterinary Care With Opening of Leanne B. Roberts Animal Care Center 4Health News:RadPharm Finds Cure to Efficiently Manage Regulated Documents with EMC 2Health News:RadPharm Finds Cure to Efficiently Manage Regulated Documents with EMC 3Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 2Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 3Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 4Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 5Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 6Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 7Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 2Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 3
... This comfortable pre-fabricated orthosis is designed ... distal third humeral diaphyseal fractures. The ... circumferential soft tissue compression for optimal ... range-of- motion of both shoulder and ...
... comfortable pre-fabricated orthosis is designed for ... third humeral diaphyseal fractures. The lightweight ... soft tissue compression for optimal control ... range-of-motion of both the shoulder and ...
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion...
... Splint is indicated for the treatment of ... economical and easy to apply. The splint ... dorsiflexion, limiting nightly contractures and tightening of ... feature permits flexibility in the treatment of ...
Medicine Products: